The global Recombinant Human Parathyroid Hormone market was valued at 149 million in 2024 and is projected to reach US$ 243 million by 2031, at a CAGR of 7.4% during the forecast period.
Recombinant Human Parathyroid Hormone is an artificially manufactured form of the parathyroid hormone used to treat hypoparathyroidism. Recombinant human parathyroid hormone is used in the treatment of osteoporosis in postmenopausal women at high risk of osteoporotic fractures. A significant reduction in the incidence of vertebral fractures has been demonstrated.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Recombinant Human Parathyroid Hormone manufacturers, suppliers, distributors, and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Recombinant Human Parathyroid Hormone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Human Parathyroid Hormone. This report contains market size and forecasts of Recombinant Human Parathyroid Hormone in global, including the following market information:
Global Recombinant Human Parathyroid Hormone market revenue, 2020-2025, 2026-2031, ($ millions)
Global Recombinant Human Parathyroid Hormone market sales, 2020-2025, 2026-2031, (K Units)
Global top five Recombinant Human Parathyroid Hormone companies in 2024 (%)
Total Market by Segment:
Global Recombinant Human Parathyroid Hormone market, by Type, 2020-2025, 2026-2031 ($ millions) & (K Units)
Global Recombinant Human Parathyroid Hormone market segment percentages, by Type, 2024 (%)
25 mcg/dose
50 mcg/dose
75 mcg/dose
100 mcg/dose
Global Recombinant Human Parathyroid Hormone market, by Application, 2020-2025, 2026-2031 ($ Millions) & (K Units)
Global Recombinant Human Parathyroid Hormone market segment percentages, by Application, 2024 (%)
Postmenopausal Women with Osteoporosis
Hypocalcemia in Patients with Hypoparathyroidism
Global Recombinant Human Parathyroid Hormone market, by region and country, 2020-2025, 2026-2031 ($ millions) & (K Units)
Global Recombinant Human Parathyroid Hormone market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Recombinant Human Parathyroid Hormone revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Recombinant Human Parathyroid Hormone revenues share in global market, 2024 (%)
Key companies Recombinant Human Parathyroid Hormone sales in global market, 2020-2025 (estimated), (K Units)
Key companies Recombinant Human Parathyroid Hormone sales share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
NPS Pharma(Shire)
Takeda
Shandong Buchang Pharmaceuticals
Ascendis Pharma
Beijing SL Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Recombinant Human Parathyroid Hormone, market overview.
Chapter 2: Global Recombinant Human Parathyroid Hormone market size in revenue and volume.
Chapter 3: Detailed analysis of Recombinant Human Parathyroid Hormone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Recombinant Human Parathyroid Hormone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Recombinant Human Parathyroid Hormone capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Recombinant Human Parathyroid Hormone Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Recombinant Human Parathyroid Hormone Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Recombinant Human Parathyroid Hormone Overall Market Size
2.1 Global Recombinant Human Parathyroid Hormone Market Size: 2024 VS 2031
2.2 Global Recombinant Human Parathyroid Hormone Market Size, Prospects & Forecasts: 2020-2031
2.3 Global Recombinant Human Parathyroid Hormone Sales: 2020-2031
3 Company Landscape
3.1 Top Recombinant Human Parathyroid Hormone Players in Global Market
3.2 Top Global Recombinant Human Parathyroid Hormone Companies Ranked by Revenue
3.3 Global Recombinant Human Parathyroid Hormone Revenue by Companies
3.4 Global Recombinant Human Parathyroid Hormone Sales by Companies
3.5 Global Recombinant Human Parathyroid Hormone Price by Manufacturer (2020-2025)
3.6 Top 3 and Top 5 Recombinant Human Parathyroid Hormone Companies in Global Market, by Revenue in 2024
3.7 Global Manufacturers Recombinant Human Parathyroid Hormone Product Type
3.8 Tier 1, Tier 2, and Tier 3 Recombinant Human Parathyroid Hormone Players in Global Market
3.8.1 List of Global Tier 1 Recombinant Human Parathyroid Hormone Companies
3.8.2 List of Global Tier 2 and Tier 3 Recombinant Human Parathyroid Hormone Companies
4 Sights by Product
4.1 Overview
4.1.1 Segment by Type - Global Recombinant Human Parathyroid Hormone Market Size Markets, 2024 & 2031
4.1.2 25 mcg/dose
4.1.3 50 mcg/dose
4.1.4 75 mcg/dose
4.1.5 100 mcg/dose
4.2 Segment by Type - Global Recombinant Human Parathyroid Hormone Revenue & Forecasts
4.2.1 Segment by Type - Global Recombinant Human Parathyroid Hormone Revenue, 2020-2025
4.2.2 Segment by Type - Global Recombinant Human Parathyroid Hormone Revenue, 2026-2031
4.2.3 Segment by Type - Global Recombinant Human Parathyroid Hormone Revenue Market Share, 2020-2031
4.3 Segment by Type - Global Recombinant Human Parathyroid Hormone Sales & Forecasts
4.3.1 Segment by Type - Global Recombinant Human Parathyroid Hormone Sales, 2020-2025
4.3.2 Segment by Type - Global Recombinant Human Parathyroid Hormone Sales, 2026-2031
4.3.3 Segment by Type - Global Recombinant Human Parathyroid Hormone Sales Market Share, 2020-2031
4.4 Segment by Type - Global Recombinant Human Parathyroid Hormone Price (Manufacturers Selling Prices), 2020-2031
5 Sights by Application
5.1 Overview
5.1.1 Segment by Application - Global Recombinant Human Parathyroid Hormone Market Size, 2024 & 2031
5.1.2 Postmenopausal Women with Osteoporosis
5.1.3 Hypocalcemia in Patients with Hypoparathyroidism
5.2 Segment by Application - Global Recombinant Human Parathyroid Hormone Revenue & Forecasts
5.2.1 Segment by Application - Global Recombinant Human Parathyroid Hormone Revenue, 2020-2025
5.2.2 Segment by Application - Global Recombinant Human Parathyroid Hormone Revenue, 2026-2031
5.2.3 Segment by Application - Global Recombinant Human Parathyroid Hormone Revenue Market Share, 2020-2031
5.3 Segment by Application - Global Recombinant Human Parathyroid Hormone Sales & Forecasts
5.3.1 Segment by Application - Global Recombinant Human Parathyroid Hormone Sales, 2020-2025
5.3.2 Segment by Application - Global Recombinant Human Parathyroid Hormone Sales, 2026-2031
5.3.3 Segment by Application - Global Recombinant Human Parathyroid Hormone Sales Market Share, 2020-2031
5.4 Segment by Application - Global Recombinant Human Parathyroid Hormone Price (Manufacturers Selling Prices), 2020-2031
6 Sights by Region
6.1 By Region - Global Recombinant Human Parathyroid Hormone Market Size, 2024 & 2031
6.2 By Region - Global Recombinant Human Parathyroid Hormone Revenue & Forecasts
6.2.1 By Region - Global Recombinant Human Parathyroid Hormone Revenue, 2020-2025
6.2.2 By Region - Global Recombinant Human Parathyroid Hormone Revenue, 2026-2031
6.2.3 By Region - Global Recombinant Human Parathyroid Hormone Revenue Market Share, 2020-2031
6.3 By Region - Global Recombinant Human Parathyroid Hormone Sales & Forecasts
6.3.1 By Region - Global Recombinant Human Parathyroid Hormone Sales, 2020-2025
6.3.2 By Region - Global Recombinant Human Parathyroid Hormone Sales, 2026-2031
6.3.3 By Region - Global Recombinant Human Parathyroid Hormone Sales Market Share, 2020-2031
6.4 North America
6.4.1 By Country - North America Recombinant Human Parathyroid Hormone Revenue, 2020-2031
6.4.2 By Country - North America Recombinant Human Parathyroid Hormone Sales, 2020-2031
6.4.3 United States Recombinant Human Parathyroid Hormone Market Size, 2020-2031
6.4.4 Canada Recombinant Human Parathyroid Hormone Market Size, 2020-2031
6.4.5 Mexico Recombinant Human Parathyroid Hormone Market Size, 2020-2031
6.5 Europe
6.5.1 By Country - Europe Recombinant Human Parathyroid Hormone Revenue, 2020-2031
6.5.2 By Country - Europe Recombinant Human Parathyroid Hormone Sales, 2020-2031
6.5.3 Germany Recombinant Human Parathyroid Hormone Market Size, 2020-2031
6.5.4 France Recombinant Human Parathyroid Hormone Market Size, 2020-2031
6.5.5 U.K. Recombinant Human Parathyroid Hormone Market Size, 2020-2031
6.5.6 Italy Recombinant Human Parathyroid Hormone Market Size, 2020-2031
6.5.7 Russia Recombinant Human Parathyroid Hormone Market Size, 2020-2031
6.5.8 Nordic Countries Recombinant Human Parathyroid Hormone Market Size, 2020-2031
6.5.9 Benelux Recombinant Human Parathyroid Hormone Market Size, 2020-2031
6.6 Asia
6.6.1 By Region - Asia Recombinant Human Parathyroid Hormone Revenue, 2020-2031
6.6.2 By Region - Asia Recombinant Human Parathyroid Hormone Sales, 2020-2031
6.6.3 China Recombinant Human Parathyroid Hormone Market Size, 2020-2031
6.6.4 Japan Recombinant Human Parathyroid Hormone Market Size, 2020-2031
6.6.5 South Korea Recombinant Human Parathyroid Hormone Market Size, 2020-2031
6.6.6 Southeast Asia Recombinant Human Parathyroid Hormone Market Size, 2020-2031
6.6.7 India Recombinant Human Parathyroid Hormone Market Size, 2020-2031
6.7 South America
6.7.1 By Country - South America Recombinant Human Parathyroid Hormone Revenue, 2020-2031
6.7.2 By Country - South America Recombinant Human Parathyroid Hormone Sales, 2020-2031
6.7.3 Brazil Recombinant Human Parathyroid Hormone Market Size, 2020-2031
6.7.4 Argentina Recombinant Human Parathyroid Hormone Market Size, 2020-2031
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Recombinant Human Parathyroid Hormone Revenue, 2020-2031
6.8.2 By Country - Middle East & Africa Recombinant Human Parathyroid Hormone Sales, 2020-2031
6.8.3 Turkey Recombinant Human Parathyroid Hormone Market Size, 2020-2031
6.8.4 Israel Recombinant Human Parathyroid Hormone Market Size, 2020-2031
6.8.5 Saudi Arabia Recombinant Human Parathyroid Hormone Market Size, 2020-2031
6.8.6 UAE Recombinant Human Parathyroid Hormone Market Size, 2020-2031
7 Manufacturers & Brands Profiles
7.1 NPS Pharma(Shire)
7.1.1 NPS Pharma(Shire) Company Summary
7.1.2 NPS Pharma(Shire) Business Overview
7.1.3 NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Major Product Offerings
7.1.4 NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Sales and Revenue in Global (2020-2025)
7.1.5 NPS Pharma(Shire) Key News & Latest Developments
7.2 Takeda
7.2.1 Takeda Company Summary
7.2.2 Takeda Business Overview
7.2.3 Takeda Recombinant Human Parathyroid Hormone Major Product Offerings
7.2.4 Takeda Recombinant Human Parathyroid Hormone Sales and Revenue in Global (2020-2025)
7.2.5 Takeda Key News & Latest Developments
7.3 Shandong Buchang Pharmaceuticals
7.3.1 Shandong Buchang Pharmaceuticals Company Summary
7.3.2 Shandong Buchang Pharmaceuticals Business Overview
7.3.3 Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Major Product Offerings
7.3.4 Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Sales and Revenue in Global (2020-2025)
7.3.5 Shandong Buchang Pharmaceuticals Key News & Latest Developments
7.4 Ascendis Pharma
7.4.1 Ascendis Pharma Company Summary
7.4.2 Ascendis Pharma Business Overview
7.4.3 Ascendis Pharma Recombinant Human Parathyroid Hormone Major Product Offerings
7.4.4 Ascendis Pharma Recombinant Human Parathyroid Hormone Sales and Revenue in Global (2020-2025)
7.4.5 Ascendis Pharma Key News & Latest Developments
7.5 Beijing SL Pharmaceutical
7.5.1 Beijing SL Pharmaceutical Company Summary
7.5.2 Beijing SL Pharmaceutical Business Overview
7.5.3 Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Major Product Offerings
7.5.4 Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Sales and Revenue in Global (2020-2025)
7.5.5 Beijing SL Pharmaceutical Key News & Latest Developments
8 Global Recombinant Human Parathyroid Hormone Production Capacity, Analysis
8.1 Global Recombinant Human Parathyroid Hormone Production Capacity, 2020-2031
8.2 Recombinant Human Parathyroid Hormone Production Capacity of Key Manufacturers in Global Market
8.3 Global Recombinant Human Parathyroid Hormone Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Recombinant Human Parathyroid Hormone Supply Chain Analysis
10.1 Recombinant Human Parathyroid Hormone Industry Value Chain
10.2 Recombinant Human Parathyroid Hormone Upstream Market
10.3 Recombinant Human Parathyroid Hormone Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Recombinant Human Parathyroid Hormone Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Recombinant Human Parathyroid Hormone in Global Market
Table 2. Top Recombinant Human Parathyroid Hormone Players in Global Market, Ranking by Revenue (2024)
Table 3. Global Recombinant Human Parathyroid Hormone Revenue by Companies, (US$, Mn), 2020-2025
Table 4. Global Recombinant Human Parathyroid Hormone Revenue Share by Companies, 2020-2025
Table 5. Global Recombinant Human Parathyroid Hormone Sales by Companies, (K Units), 2020-2025
Table 6. Global Recombinant Human Parathyroid Hormone Sales Share by Companies, 2020-2025
Table 7. Key Manufacturers Recombinant Human Parathyroid Hormone Price (2020-2025) & (US$/Unit)
Table 8. Global Manufacturers Recombinant Human Parathyroid Hormone Product Type
Table 9. List of Global Tier 1 Recombinant Human Parathyroid Hormone Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Recombinant Human Parathyroid Hormone Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segment by Type – Global Recombinant Human Parathyroid Hormone Revenue, (US$, Mn), 2024 & 2031
Table 12. Segment by Type - Global Recombinant Human Parathyroid Hormone Revenue (US$, Mn), 2020-2025
Table 13. Segment by Type - Global Recombinant Human Parathyroid Hormone Revenue (US$, Mn), 2026-2031
Table 14. Segment by Type - Global Recombinant Human Parathyroid Hormone Sales (K Units), 2020-2025
Table 15. Segment by Type - Global Recombinant Human Parathyroid Hormone Sales (K Units), 2026-2031
Table 16. Segment by Application – Global Recombinant Human Parathyroid Hormone Revenue, (US$, Mn), 2024 & 2031
Table 17. Segment by Application - Global Recombinant Human Parathyroid Hormone Revenue, (US$, Mn), 2020-2025
Table 18. Segment by Application - Global Recombinant Human Parathyroid Hormone Revenue, (US$, Mn), 2026-2031
Table 19. Segment by Application - Global Recombinant Human Parathyroid Hormone Sales, (K Units), 2020-2025
Table 20. Segment by Application - Global Recombinant Human Parathyroid Hormone Sales, (K Units), 2026-2031
Table 21. By Region – Global Recombinant Human Parathyroid Hormone Revenue, (US$, Mn), 2025-2031
Table 22. By Region - Global Recombinant Human Parathyroid Hormone Revenue, (US$, Mn), 2020-2025
Table 23. By Region - Global Recombinant Human Parathyroid Hormone Revenue, (US$, Mn), 2026-2031
Table 24. By Region - Global Recombinant Human Parathyroid Hormone Sales, (K Units), 2020-2025
Table 25. By Region - Global Recombinant Human Parathyroid Hormone Sales, (K Units), 2026-2031
Table 26. By Country - North America Recombinant Human Parathyroid Hormone Revenue, (US$, Mn), 2020-2025
Table 27. By Country - North America Recombinant Human Parathyroid Hormone Revenue, (US$, Mn), 2026-2031
Table 28. By Country - North America Recombinant Human Parathyroid Hormone Sales, (K Units), 2020-2025
Table 29. By Country - North America Recombinant Human Parathyroid Hormone Sales, (K Units), 2026-2031
Table 30. By Country - Europe Recombinant Human Parathyroid Hormone Revenue, (US$, Mn), 2020-2025
Table 31. By Country - Europe Recombinant Human Parathyroid Hormone Revenue, (US$, Mn), 2026-2031
Table 32. By Country - Europe Recombinant Human Parathyroid Hormone Sales, (K Units), 2020-2025
Table 33. By Country - Europe Recombinant Human Parathyroid Hormone Sales, (K Units), 2026-2031
Table 34. By Region - Asia Recombinant Human Parathyroid Hormone Revenue, (US$, Mn), 2020-2025
Table 35. By Region - Asia Recombinant Human Parathyroid Hormone Revenue, (US$, Mn), 2026-2031
Table 36. By Region - Asia Recombinant Human Parathyroid Hormone Sales, (K Units), 2020-2025
Table 37. By Region - Asia Recombinant Human Parathyroid Hormone Sales, (K Units), 2026-2031
Table 38. By Country - South America Recombinant Human Parathyroid Hormone Revenue, (US$, Mn), 2020-2025
Table 39. By Country - South America Recombinant Human Parathyroid Hormone Revenue, (US$, Mn), 2026-2031
Table 40. By Country - South America Recombinant Human Parathyroid Hormone Sales, (K Units), 2020-2025
Table 41. By Country - South America Recombinant Human Parathyroid Hormone Sales, (K Units), 2026-2031
Table 42. By Country - Middle East & Africa Recombinant Human Parathyroid Hormone Revenue, (US$, Mn), 2020-2025
Table 43. By Country - Middle East & Africa Recombinant Human Parathyroid Hormone Revenue, (US$, Mn), 2026-2031
Table 44. By Country - Middle East & Africa Recombinant Human Parathyroid Hormone Sales, (K Units), 2020-2025
Table 45. By Country - Middle East & Africa Recombinant Human Parathyroid Hormone Sales, (K Units), 2026-2031
Table 46. NPS Pharma(Shire) Company Summary
Table 47. NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Product Offerings
Table 48. NPS Pharma(Shire) Recombinant Human Parathyroid Hormone Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 49. NPS Pharma(Shire) Key News & Latest Developments
Table 50. Takeda Company Summary
Table 51. Takeda Recombinant Human Parathyroid Hormone Product Offerings
Table 52. Takeda Recombinant Human Parathyroid Hormone Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 53. Takeda Key News & Latest Developments
Table 54. Shandong Buchang Pharmaceuticals Company Summary
Table 55. Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Product Offerings
Table 56. Shandong Buchang Pharmaceuticals Recombinant Human Parathyroid Hormone Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 57. Shandong Buchang Pharmaceuticals Key News & Latest Developments
Table 58. Ascendis Pharma Company Summary
Table 59. Ascendis Pharma Recombinant Human Parathyroid Hormone Product Offerings
Table 60. Ascendis Pharma Recombinant Human Parathyroid Hormone Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 61. Ascendis Pharma Key News & Latest Developments
Table 62. Beijing SL Pharmaceutical Company Summary
Table 63. Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Product Offerings
Table 64. Beijing SL Pharmaceutical Recombinant Human Parathyroid Hormone Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 65. Beijing SL Pharmaceutical Key News & Latest Developments
Table 66. Recombinant Human Parathyroid Hormone Capacity of Key Manufacturers in Global Market, 2023-2025 (K Units)
Table 67. Global Recombinant Human Parathyroid Hormone Capacity Market Share of Key Manufacturers, 2023-2025
Table 68. Global Recombinant Human Parathyroid Hormone Production by Region, 2020-2025 (K Units)
Table 69. Global Recombinant Human Parathyroid Hormone Production by Region, 2026-2031 (K Units)
Table 70. Recombinant Human Parathyroid Hormone Market Opportunities & Trends in Global Market
Table 71. Recombinant Human Parathyroid Hormone Market Drivers in Global Market
Table 72. Recombinant Human Parathyroid Hormone Market Restraints in Global Market
Table 73. Recombinant Human Parathyroid Hormone Raw Materials
Table 74. Recombinant Human Parathyroid Hormone Raw Materials Suppliers in Global Market
Table 75. Typical Recombinant Human Parathyroid Hormone Downstream
Table 76. Recombinant Human Parathyroid Hormone Downstream Clients in Global Market
Table 77. Recombinant Human Parathyroid Hormone Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Recombinant Human Parathyroid Hormone Product Picture
Figure 2. Recombinant Human Parathyroid Hormone Segment by Type in 2024
Figure 3. Recombinant Human Parathyroid Hormone Segment by Application in 2024
Figure 4. Global Recombinant Human Parathyroid Hormone Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Recombinant Human Parathyroid Hormone Market Size: 2024 VS 2031 (US$, Mn)
Figure 7. Global Recombinant Human Parathyroid Hormone Revenue: 2020-2031 (US$, Mn)
Figure 8. Recombinant Human Parathyroid Hormone Sales in Global Market: 2020-2031 (K Units)
Figure 9. The Top 3 and 5 Players Market Share by Recombinant Human Parathyroid Hormone Revenue in 2024
Figure 10. Segment by Type – Global Recombinant Human Parathyroid Hormone Revenue, (US$, Mn), 2024 & 2031
Figure 11. Segment by Type - Global Recombinant Human Parathyroid Hormone Revenue Market Share, 2020-2031
Figure 12. Segment by Type - Global Recombinant Human Parathyroid Hormone Sales Market Share, 2020-2031
Figure 13. Segment by Type - Global Recombinant Human Parathyroid Hormone Price (US$/Unit), 2020-2031
Figure 14. Segment by Application – Global Recombinant Human Parathyroid Hormone Revenue, (US$, Mn), 2024 & 2031
Figure 15. Segment by Application - Global Recombinant Human Parathyroid Hormone Revenue Market Share, 2020-2031
Figure 16. Segment by Application - Global Recombinant Human Parathyroid Hormone Sales Market Share, 2020-2031
Figure 17. Segment by Application -Global Recombinant Human Parathyroid Hormone Price (US$/Unit), 2020-2031
Figure 18. By Region – Global Recombinant Human Parathyroid Hormone Revenue, (US$, Mn), 2025 & 2031
Figure 19. By Region - Global Recombinant Human Parathyroid Hormone Revenue Market Share, 2020 VS 2024 VS 2031
Figure 20. By Region - Global Recombinant Human Parathyroid Hormone Revenue Market Share, 2020-2031
Figure 21. By Region - Global Recombinant Human Parathyroid Hormone Sales Market Share, 2020-2031
Figure 22. By Country - North America Recombinant Human Parathyroid Hormone Revenue Market Share, 2020-2031
Figure 23. By Country - North America Recombinant Human Parathyroid Hormone Sales Market Share, 2020-2031
Figure 24. United States Recombinant Human Parathyroid Hormone Revenue, (US$, Mn), 2020-2031
Figure 25. Canada Recombinant Human Parathyroid Hormone Revenue, (US$, Mn), 2020-2031
Figure 26. Mexico Recombinant Human Parathyroid Hormone Revenue, (US$, Mn), 2020-2031
Figure 27. By Country - Europe Recombinant Human Parathyroid Hormone Revenue Market Share, 2020-2031
Figure 28. By Country - Europe Recombinant Human Parathyroid Hormone Sales Market Share, 2020-2031
Figure 29. Germany Recombinant Human Parathyroid Hormone Revenue, (US$, Mn), 2020-2031
Figure 30. France Recombinant Human Parathyroid Hormone Revenue, (US$, Mn), 2020-2031
Figure 31. U.K. Recombinant Human Parathyroid Hormone Revenue, (US$, Mn), 2020-2031
Figure 32. Italy Recombinant Human Parathyroid Hormone Revenue, (US$, Mn), 2020-2031
Figure 33. Russia Recombinant Human Parathyroid Hormone Revenue, (US$, Mn), 2020-2031
Figure 34. Nordic Countries Recombinant Human Parathyroid Hormone Revenue, (US$, Mn), 2020-2031
Figure 35. Benelux Recombinant Human Parathyroid Hormone Revenue, (US$, Mn), 2020-2031
Figure 36. By Region - Asia Recombinant Human Parathyroid Hormone Revenue Market Share, 2020-2031
Figure 37. By Region - Asia Recombinant Human Parathyroid Hormone Sales Market Share, 2020-2031
Figure 38. China Recombinant Human Parathyroid Hormone Revenue, (US$, Mn), 2020-2031
Figure 39. Japan Recombinant Human Parathyroid Hormone Revenue, (US$, Mn), 2020-2031
Figure 40. South Korea Recombinant Human Parathyroid Hormone Revenue, (US$, Mn), 2020-2031
Figure 41. Southeast Asia Recombinant Human Parathyroid Hormone Revenue, (US$, Mn), 2020-2031
Figure 42. India Recombinant Human Parathyroid Hormone Revenue, (US$, Mn), 2020-2031
Figure 43. By Country - South America Recombinant Human Parathyroid Hormone Revenue Market Share, 2020-2031
Figure 44. By Country - South America Recombinant Human Parathyroid Hormone Sales, Market Share, 2020-2031
Figure 45. Brazil Recombinant Human Parathyroid Hormone Revenue, (US$, Mn), 2020-2031
Figure 46. Argentina Recombinant Human Parathyroid Hormone Revenue, (US$, Mn), 2020-2031
Figure 47. By Country - Middle East & Africa Recombinant Human Parathyroid Hormone Revenue, Market Share, 2020-2031
Figure 48. By Country - Middle East & Africa Recombinant Human Parathyroid Hormone Sales, Market Share, 2020-2031
Figure 49. Turkey Recombinant Human Parathyroid Hormone Revenue, (US$, Mn), 2020-2031
Figure 50. Israel Recombinant Human Parathyroid Hormone Revenue, (US$, Mn), 2020-2031
Figure 51. Saudi Arabia Recombinant Human Parathyroid Hormone Revenue, (US$, Mn), 2020-2031
Figure 52. UAE Recombinant Human Parathyroid Hormone Revenue, (US$, Mn), 2020-2031
Figure 53. Global Recombinant Human Parathyroid Hormone Production Capacity (K Units), 2020-2031
Figure 54. The Percentage of Production Recombinant Human Parathyroid Hormone by Region, 2024 VS 2031
Figure 55. Recombinant Human Parathyroid Hormone Industry Value Chain
Figure 56. Marketing Channels
